83 related articles for article (PubMed ID: 22435140)
1. Angiogenic response of advanced glycation end products (AGEs) involves PPARgamma.
Devi MS; Sudhakaran PR
Indian J Biochem Biophys; 2012 Feb; 49(1):18-24. PubMed ID: 22435140
[TBL] [Abstract][Full Text] [Related]
2. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
[TBL] [Abstract][Full Text] [Related]
3. Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advanced glycation end products through activation of peroxisome proliferators-activated receptor gamma.
Ma L; Gao HQ; Li BY; Ma YB; You BA; Zhang FL
J Cardiovasc Pharmacol; 2007 May; 49(5):293-8. PubMed ID: 17513948
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of angiogenesis by advanced glycation end products.
Devi MS; Sudhakaran PR
Exp Biol Med (Maywood); 2011 Jan; 236(1):52-61. PubMed ID: 21148738
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell response to lactate: implication of PAR modification of VEGF.
Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
[TBL] [Abstract][Full Text] [Related]
6. Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators.
Meng D; Liu N
Chin Med J (Engl); 2003 Sep; 116(9):1336-40. PubMed ID: 14527361
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
[TBL] [Abstract][Full Text] [Related]
8. [Effect of atorvastatin on advanced glycation end products induced monocyte chemoattractant protein-1 expression in cultured human endothelial cells].
Xu SH; Wang KF; Xu CS; Xie LD
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):512-7. PubMed ID: 21924076
[TBL] [Abstract][Full Text] [Related]
9. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells.
Iwashima Y; Eto M; Horiuchi S; Sano H
Biochem Biophys Res Commun; 1999 Oct; 264(2):441-8. PubMed ID: 10529383
[TBL] [Abstract][Full Text] [Related]
12. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
Aljada A; O'Connor L; Fu YY; Mousa SA
Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products induce angiogenesis in vivo.
Okamoto T; Tanaka S; Stan AC; Koike T; Kase M; Makita Z; Sawa H; Nagashima K
Microvasc Res; 2002 Mar; 63(2):186-95. PubMed ID: 11866542
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells.
Stitt AW; He C; Vlassara H
Biochem Biophys Res Commun; 1999 Mar; 256(3):549-56. PubMed ID: 10080935
[TBL] [Abstract][Full Text] [Related]
15. Opposing effects of curcuminoids on serum stimulated and unstimulated angiogenic response.
Kiran MS; Kumar VB; Viji RI; Sherin GT; Rajasekharan KN; Sudhakaran PR
J Cell Physiol; 2008 Apr; 215(1):251-64. PubMed ID: 17960570
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
Biscetti F; Gaetani E; Flex A; Aprahamian T; Hopkins T; Straface G; Pecorini G; Stigliano E; Smith RC; Angelini F; Castellot JJ; Pola R
Diabetes; 2008 May; 57(5):1394-404. PubMed ID: 18268046
[TBL] [Abstract][Full Text] [Related]
17. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709
[TBL] [Abstract][Full Text] [Related]
18. The role of ribosylated-BSA in regulating PC12 cell viability.
Kuo TY; Huang CL; Yang JM; Huang WJ; Huang NK; Chen YW; Lin RJ; Yang YC
Cell Biol Toxicol; 2012 Aug; 28(4):255-67. PubMed ID: 22543687
[TBL] [Abstract][Full Text] [Related]
19. Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells.
Albertin G; Guidolin D; Sorato E; Oselladore B; Tortorella C; Ribatti D
Regul Pept; 2011 Dec; 172(1-3):16-22. PubMed ID: 21871928
[TBL] [Abstract][Full Text] [Related]
20. PPARgamma-mediated advanced glycation end products regulation of neural stem cells.
Wang SH; Sun ZL; Guo YJ; Yuan Y; Li L
Mol Cell Endocrinol; 2009 Aug; 307(1-2):176-84. PubMed ID: 19524138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
